QBE Insurance Group Limited
QBE Insurance Group Limited (QBIEY) Financial Performance & Income Statement Overview
Explore the financials of QBE Insurance Group Limited (QBIEY), including yearly and quarterly data on income, cash flow, and balance sheets.
QBE Insurance Group Limited (QBIEY) Income Statement & Financial Overview
Review QBE Insurance Group Limited QBIEY income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $11.85B | $10.86B | $11.50B | $10.18B |
| Cost of Revenue | $0.00 | $0.00 | -$339.78M | $54.61M |
| Gross Profit | $11.85B | $10.86B | $11.84B | $10.12B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.03 | $0.99 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $0.00 | $0.00 | $10.19B | $9.48B |
| Total Costs & Expenses | $0.00 | $0.00 | $10.19B | $9.48B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $125.21M | $110.10M |
| Depreciation & Amortization | $0.00 | -$4.00M | -$1.47B | -$627.00M |
| EBITDA | $0.00 | $21.71B | -$244.00M | -$72.00M |
| EBITDA Ratio | $0.00 | $2.00 | -$0.02 | -$0.007 |
| Operating Income | $11.85B | $10.86B | $11.50B | $627.00M |
| Operating Income Ratio | $1.00 | $1.00 | $1.00 | $0.06 |
| Other Income/Expenses (Net) | -$10.61B | -$9.81B | -$10.25B | -$9.66B |
| Income Before Tax | $1.24B | $1.05B | $1.25B | $584.00M |
| Income Before Tax Ratio | $0.10 | $0.10 | $0.11 | $0.06 |
| Income Tax Expense | $259.00M | $245.00M | $293.00M | $180.00M |
| Net Income | $977.00M | $802.00M | $955.00M | $375.00M |
| Net Income Ratio | $0.08 | $0.07 | $0.08 | $0.04 |
| EPS | $0.63 | $0.52 | $0.62 | $0.25 |
| Diluted EPS | $0.63 | $0.52 | $0.64 | $0.25 |
| Weighted Avg Shares Outstanding | $1.56B | $1.56B | $1.54B | $1.50B |
| Weighted Avg Shares Outstanding (Diluted) | $1.52B | $1.51B | $1.50B | $1.50B |
Over the past four quarters, QBE Insurance Group Limited demonstrated steady revenue growth, increasing from $10.18B in Q2 2023 to $11.85B in Q4 2024. Operating income reached $11.85B in Q4 2024, maintaining a consistent 100% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $0.00, reflecting operational efficiency. Net income rose to $977.00M, with EPS at $0.63. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan